4//SEC Filing
Katz Michael David M.D. 4
Accession 0001619964-25-000015
CIK 0001828588other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 3:51 PM ET
Size
7.1 KB
Accession
0001619964-25-000015
Insider Transaction Report
Form 4
Katz Michael David M.D.
Director
Transactions
- Award
Common Stock
2025-01-29+1,331→ 150,610 total
Holdings
- 40(indirect: See Footnote 2)
Common Stock
- 96,760(indirect: See Footnote 3)
Common Stock
- 25(indirect: See Footnote 2)
Common Stock
Footnotes (3)
- [F1]Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2026, February 20, 2027, February 20, 2028, February 20, 2029, and February 20, 2030.
- [F2]Held as custodian for Dr. Katz's grandchild
- [F3]Held by a trust to which Dr. Katz is a beneficiary
Documents
Issuer
Hanover Bancorp, Inc. /NY
CIK 0001828588
Entity typeother
Related Parties
1- filerCIK 0001919798
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 3:51 PM ET
- Size
- 7.1 KB